The global Veterinary Medicine market size is expected to be worth around US$ 48.2billion by 2028, according to a new report by Vision Research Reports.
The global Veterinary Medicine market size was valued at US$ 30.1 billion in 2020 and is anticipated to grow at a CAGR of 7.6% during forecast period 2021 to 2028.
Growth Factors
An increase in the number of pet owners is driving the need for better treatment options for companion animals, which is resulting in rising health expenditure on pets. According to The American Pet Products Association, the overall spending in the U.S. pet industry increased to USD 95.7 billion in 2019 from USD 90.5 billion in 2018, and it is estimated to reach USD 99.0 billion in 2020.
Growing consumption of meat is fueling the demand for mandatory vaccination for animals, which results in market growth. According to The World Counts, Denmark, global meat production has increased 2-fold from 1988 to 2018. It also stated that meat consumption is estimated to range between 460-570 million tons by 2050. Such factors are expected to drive the growth of the market during the forecast period.
The market leaders are involved in strategic collaborations, regional expansions, and new product launches to sustain the competition. For instance, Elanco acquired Bayer’s division in August 2020 in an attempt to strengthen its R&D capabilities, e-Commerce presence, and multiply its product portfolio. Additionally, in March 2020, Virbac signed an agreement with Pebble Labs for the co-development and commercialization of products for disease prevention in aquatic animals.
Report Highlights
The production animal segment led the market for veterinary medicine and accounted for more than 50.0% share of the global revenue in 2019. The production animal segment is further classified into swine, poultry, cattle, fish, and sheep & goats. The dominant share captured by production animals is a consequence of the rising demand for proteins in the world. Additionally, increasing spending on especially in the developed regions, is also presumed to be responsible for the wide-scale adoption of production animals. According to USDA (United States Department of Agriculture) NASS (National Agricultural Statistics Service), the total production from eggs, broilers, & turkey, and the value of sales from chicken, was USD 46.3 billion in 2020, an increase of about 8% from USD 42.7 billion in 2017.
The companion animal segment is expected to demonstrate the fastest growth over the forecast period owing to the increasing prevalence of chronic diseases. The companion animal is further sub-segmented into horses, cats, dogs & others. Dogs took about 40% share of the segment due to the rising demand for advanced treatment alternatives for canines suffering from chronic diseases. As per an AVMA report, in the U.S., spending on pets reached about USD 95.7 billion in 2020, with dogs and cats contributing to a dominant share. The above-mentioned factors are expected to propel the market for veterinary medicine over the forecasted period.
The pharmaceuticals segment dominated the market for veterinary medicine and held the largest revenue share of 57.8% in 2020, owing to the rising prevalence of zoonotic diseases, brucellosis, and food-borne diseases. The pharmaceuticals segment is further divided into anti-infectives, parasiticides, analgesics, anti-inflammatory, and others. The biologics segment is further bifurcated into vaccines and others. Others include monoclonal antibodies, immunomodulators, and hormonal supplements.
The medicinal feed additives segment is also expected to witness a significant growth rate owing to their increasing usage in maintaining animal health. Furthermore, the rising global population is increasing the demand for meat as well as dairy, which also drives the growth of the medicinal feed additives segment.
The parenteral segment held the largest revenue share of over 44.0% as of 2020. The growth can be credited to the product availability and instant onset of action. On the basis of mode of delivery, the market for veterinary medicine is segmented into oral, parenteral, and others. Others include topical, targeted drug delivery, etc. The therapeutic effect for parenteral drugs is usually achieved within an hour after the administration, thus it is preferred for faster action.
The oral segment is projected to witness the fastest CAGR owing to the advancements in the oral veterinary medicines segment, such as chewable tablets. Moreover, the increasing prevalence of chronic conditions in pets is also expected to drive the market for veterinary medicine. For instance, in July 2020, Merck received the U.S. FDA approval for Bravecto monthly chews for dogs and puppies, hence expanding its product portfolio. Oral mode of delivery is further segmented into powder and tablets.
Other modes of administration include suspension, topical, and carrier. Among these, the topical segment is expected to hold the largest market share owing to its high adoption for the treatment of skin infections in animals. On the other hand, the carrier segment is expected to grow at the fastest growth rate owing to advancements in the segment by market players.
The veterinary hospitals and clinics segment held the largest market share of 72.3% in 2020. The growth can be attributed to the advanced diagnostic imaging, novel therapies, nuclear and regenerative medicines, laser diagnostics, and specialized surgeries, available in the veterinary hospitals and clinics. Based on end-use, the market for veterinary medicine is segmented into point-of-care testing/in-house testing, reference laboratories, veterinary hospitals and clinics, and others.
The reference laboratories segment is expected to exhibit the fastest growth over the forecast period. This growth is because these laboratories enable testing of various infections, toxic agents, and chronic diseases in the specimen which are obtained from animals. These tests include general laboratory tests as well as specialized tests.
The point-of-care testing/in-house testing segment is also expected to demonstrate a significant growth rate owing to their convenience, precise symptomatic testing, easy usage, and quick analysis. Strategic developments by companies are expected to contribute to the growth of the market for veterinary medicine. For instance, Zoetis acquired Abaxis in July 2020, which is a leader in veterinary point-of-care diagnostic instruments. Zoetis expanded its product portfolio through this.
North America dominated the market for veterinary medicine and accounted for over 38.5% share of global revenue in 2020. The dominance is followed by the European countries due to the favorable government regulations such as the EU Veterinary Medicines Regulation and increasing adoption of pet insurance in European countries.
Key contributing factors attributing to dominance are the increasing prevalence of zoonotic diseases and favorable reimbursement programs. Moreover, the increasing adoption of pet health insurance in the U.S. is also expected to contribute to the growth of the market for veterinary medicines.
Key Players
Merck Animal Health
Ceva Sante Animale
Vetoquinol S.A.
Zoetis
Boehringer Ingelheim GmbH
Elanco
Nutreco N.V.
Virbac
Kindred Biosciences, Inc.
Biogenesis Bago
Indian Immunologicals Ltd
Neogen Corporation
Hester Biosciences
Phibro Animal Health
Market Segmentation
Animal Type Outlook
Production
Poultry
Swine
Cattle
Sheep & Goats
Fish
Companion
Dogs
Cats
Horses
Others
Product Outlook
Biologics
Vaccine
Live attenuated vaccines
DNA Vaccines
Recombinant Vaccines
Inactivated Vaccines
Others
Others
Pharmaceuticals
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others
Medicated Feed Additives
Mode of Delivery Outlook
Oral
Parenteral
Others (Topical, carrier)
End-use Outlook
Reference Laboratories
Point-of-care testing/In-house testing
Veterinary Hospitals & Clinics
Others
Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
The Veterinary Medicine market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Veterinary Medicine market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Veterinary Medicine market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Veterinary Medicine market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Veterinary Medicine market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Veterinary Medicine capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Veterinary Medicine by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Veterinary Medicine market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Veterinary Medicine market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Veterinary Medicine market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Veterinary Medicine industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Veterinary Medicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Veterinary Medicine market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Veterinary Medicine market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Veterinary Medicine market. These factors have benefited the growth of the global market for Veterinary Medicine. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Veterinary Medicine. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Veterinary Medicine are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Medicine Market, By Product
7.1. Veterinary Medicine Market, by Product Type, 2020-2030
7.1.1. Biologics
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Pharmaceuticals
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Medicated Feed Additives
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Veterinary Medicine Market, By Mode of Delivery
8.1. Veterinary Medicine Market, By Mode of Delivery, 2020-2030
8.1.1. Oral
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Parenteral
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Others (Topical, carrier)
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Veterinary Medicine Market, By Animal Type
9.1. Veterinary Medicine Market, By Animal Type, 2020-2030
9.1.1. Production
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Companion
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Veterinary Medicine Market, By End-use Type
10.1. Veterinary Medicine Market, By End-use Type, 2020-2030
10.1.1. Reference Laboratories
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Point-of-care testing/In-house testing
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Veterinary Hospitals & Clinics
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Veterinary Medicine Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.1.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.1.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.2.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.2.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.3.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.3.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.4.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.4.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.5.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Mode of Delivery (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Animal Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
Chapter 12. Company Profiles
12.1. Merck Animal Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Ceva Sante Animale
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Vetoquinol S.A.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Zoetis
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Boehringer Ingelheim GmbH
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Elanco
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Nutreco N.V.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Virbac
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Kindred Biosciences, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Biogenesis Bago
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Indian Immunologicals Ltd.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Neogen Corporation
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Hester Biosciences
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Philbro Animal Health
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms